首页> 外文期刊>Nephron >Cystatin C as Predictor of Microalbuminuria in the Early Stage of Hypertension
【24h】

Cystatin C as Predictor of Microalbuminuria in the Early Stage of Hypertension

机译:胱抑素C作为高血压早期微量蛋白尿的预测因子

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Predictors of microalbuminuria in the early stage of hypertension are not well known. We did a prospective study to investigate whether glomerular hyperfiltration assessed from serum cystatin C predicts development of microalbuminuria in hypertension. Methods: We assessed 101 treatment-naive subjects screened for stage 1 hypertension and followed-up for a median 3.1 years. Cystatin C was measured at entry and glomerular filtration rate was estimated using the Hoek formula (CystGFR). Urinary albumin and ambulatory blood pressure were measured at entry and during the follow-up. Results: Subjects in the top CystGFR tertile (>115 ml/min/1.73m~2) were leaner (p = 0.002) and developed microalbuminuria more frequently (p = 0.02) than the rest of the group. In univariate Cox regression, CystGFR was associated with future microalbuminuria (hazard ratio, 1.06,95% confidence interval (CI), 1.02-1.10, p = 0.001). After controlling for baseline albumin excretion rate and several confounders, CystGFR remained a significant predic-tor of microalbuminuria development (hazard ratio, 1.19, 95% CI, 1.03-1.37, p = 0.019). The association between future microalbuminuria and creatinine clearance or glomerular filtration rate estimated with the Cockroft-Gault or the Modification of Diet in Renal Disease formula did not attain the level of statistical significance in this sample. Conclusions: The present findings indicate that CystGFR is more sensitive than creatinine clearance or estimated glomerular filtration rate for predicting microalbuminuria development in the early stage of hypertension and confirm that hyperfiltration precedes microalbuminuria in this clinical entity.
机译:背景/目的:高血压早期的微量白蛋白尿预测指标尚不清楚。我们进行了一项前瞻性研究,以调查从血清胱抑素C评估的肾小球超滤是否可预测高血压中微量白蛋白尿的发生。方法:我们评估了101名未接受过治疗的对象,这些对象经过1期高血压筛查,平均随访时间为3.1年。在进入时测量胱抑素C,并使用Hoek公式(CystGFR)估算肾小球滤过率。在入院时和随访期间测量尿白蛋白和动态血压。结果:CystGFR最高三分位数(> 115 ml / min / 1.73m〜2)中的受试者比其他组的受试者更瘦(p = 0.002)并且更频繁地出现微白蛋白尿(p = 0.02)。在单变量Cox回归中,CystGFR与未来的微量白蛋白尿相关(危险比,1.06,95%置信区间(CI),1.02-1.10,p = 0.001)。在控制了基线白蛋白排泄率和几个混杂因素之后,CystGFR仍然是微量白蛋白尿发展的重要预测者(危险比,1.19,95%CI,1.03-1.37,p = 0.019)。用Cockroft-Gault或《饮食中肾脏疾病的改良》公式估算的未来微量白蛋白尿与肌酐清除率或肾小球滤过率之间的关联在此样本中未达到统计学意义。结论:目前的发现表明,CystGFR比肌酐清除率或估计的肾小球滤过率更敏感,可预测高血压早期的微量白蛋白尿发展,并证实该临床实体中超滤先于微量白蛋白尿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号